2 Marijuana Stocks To Buy Before November 2022
Marijuana stocks are starting to see some pullback in the stock market. Now, this is not all bad as this can be a time of preparation for the next rise in trading. Some people do get frustrated when they see a drop in trading and rightfully so. However with how volatile the cannabis sector is you want to prepare yourself for the next recovery as mentioned above. The way most would prepare is to find the best marijuana stocks to buy when there is a decline. There are many projects and ventures in the worms that could be a good momentum driver for the sector.
As 2022 comes to a close 2023 is another chance for things to ramp up in the cannabis industry. Specifically, the bigger catalyst and focus would be federal cannabis reform. Whether it’s cannabis banking or the termination of cannabis prohibtion there needs to be action taken to resolve these issues. This is a big issue for America’s legal cannabis market. Even with more than half of the US having legal markets more needs to be done to make the legal transitions complete.
Once cannabis is rescheduled many believe this will create a whole new landscape for cannabis companies to do business globally without fear of federal repercussions. As well many feel on the day cannabis prohibtion is no more marijuana stocks could see one of the biggest runs in a long time. Now, none of this is set in stone and anything can happen. So in the meantime adapting your trading style to a more volatile market could produce the gains you want.
Marijuana Stocks To Trade This Month?
Trulieve Cannabis Corp.
Trulieve Cannabis Corp. together with its subsidiaries operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery.
Back on October 14th, the company announced it will be opening a medical marijuana dispensary in Land O’ Lakes, Florida. The official grand opening was on October 15th.
Words From The CEO
“Trulieve is proud to continue being at the forefront of expanding access to medical marijuana for Florida’s patient population,” said Trulieve’s Chief Executive Officer Kim Rivers. “Trulieve is committed to offering patients high-quality products and providing exceptional customer experiences.”
[Read More] 3 Marijuana Stocks That Could See More Gains Before November
Cresco Labs Inc.
Cresco Labs Inc. together with its subsidiaries cultivates, manufactures, and sells retail and medical cannabis products in the United States. In recent news, the company announced the resignation of board director Sidney Dillard.
Ms. Dillard has accepted a board position at a large national health insurance provider and is resigning from her Cresco Lab’s board position to avoid any potential regulatory conflicts.
[Read More] Top Pot Stocks To Keep On Watch Going Into 2023
Words From The Company
“We are disappointed to see Sidney go, but we wish her the best in her new endeavor. I know she will be the same trusted advisor, independent voice, and driver of evolution in her new role,” said Charles Bachtell, Cresco Labs CEO and Co-founder. “Sidney’s depth of experience and professionalism has set the bar high, and we will ensure that our board continues to have industry leading diversity of experience and knowledge.”
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | firstname.lastname@example.org